Cleared Traditional

K193454 - IQon Spectral CT

K193454 is the FDA 510(k) clearance for IQon Spectral CT by Philips Medical Systems Nederland B.V.. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 42-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
42d
Days
Class 2
Risk

K193454 is an FDA 510(k) clearance for the IQon Spectral CT. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Philips Medical Systems Nederland B.V. (Best Noord-Brabant, NL). The FDA issued a Cleared decision on January 24, 2020 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Philips Medical Systems Nederland B.V. devices

Submission Details

510(k) Number K193454 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 2019
Decision Date January 24, 2020
Days to Decision 42 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 107d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 581
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K193454.
uCT 530, uCT 550
K200016 · Shanghai United Imaging Healthcare Co., Ltd. · Feb 2020
Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i
K192832 · Canon Medical Systems Corporation · Feb 2020
Aquilion ONE (TSX-306A/3) V10.0 with Spectral Imaging System
K192828 · Canon Medical Systems Corporation · Feb 2020
Auto Positioning
K192956 · Ge Hangwei Medical Systems Co., Ltd. · Jan 2020
syngo.CT CaScoring
K192763 · Siemens Medical Solutions USA, Inc. · Dec 2019
Deep Learning Image Reconstruction
K193170 · Ge Healthcare Japan Corporation · Dec 2019